Keyphrases
Kv1.1
100%
HERG
100%
Long QT Syndrome Type 2
100%
Potassium Channel
100%
Long QT Syndrome
100%
Reactive Hypoglycemia
100%
Incretin
100%
Glucagon-like
45%
Cardiac Repolarization
45%
Glucose-dependent Insulinotropic Polypeptide
36%
Plasma Glucose
36%
Glucose Consumption
36%
Glucagon
27%
Cell Function
27%
Hypoglycemia
18%
Insulin Secretion
18%
Low Glucose
18%
Glucose Regulation
18%
C-peptide
18%
MiRNA Inhibitors
9%
Hypoglycemia Risk
9%
ECG Recording
9%
Dofetilide
9%
Glucose Level
9%
QT Interval
9%
Serum Insulin
9%
Healthy Participants
9%
K Cells
9%
75-g Oral Glucose Tolerance Test
9%
L-cells
9%
QTcF
9%
Blood Samples
9%
Voltage-gated Potassium Channel
9%
Sensitivity Index
9%
Background Loss
9%
Confidence Interval
9%
Sex Body
9%
Glucose-insulin System
9%
Glucagon Secretion
9%
Intestinal L Cells
9%
Small Interfering RNA (siRNA)
9%
Insulin
9%
Gain-of-function mutation
9%
QTc Interval
9%
Body Mass Index
9%
Insulin-like
9%
Medicine and Dentistry
Hypoglycemia
100%
Long QT Syndrome
100%
Incretin
100%
Potassium Channel
100%
Heart Repolarization
38%
Glucagon Like Peptide 1
38%
Gastric Inhibitory Polypeptide
30%
Ingestion
30%
Glucagon
23%
Cell Function
23%
C-Peptide
15%
Insulin Release
15%
Secretion (Process)
15%
Dofetilide
7%
Blood Sampling
7%
Small Interfering RNA
7%
QT Interval
7%
Insulin-Related Peptide
7%
QTc Interval
7%
Body Mass Index
7%
Voltage-Gated Potassium Channel
7%
Loss of Function Mutation
7%
Glucagon Release
7%
Oral Glucose Tolerance Test
7%
Antidiabetic Agent
7%
Electrocardiogram
7%
Biochemistry, Genetics and Molecular Biology
Incretin
100%
Potassium Channel
100%
Long QT Syndrome
100%
Glucagon-Like Peptide-1
38%
Heart Repolarization
38%
Gastric Inhibitory Polypeptide
30%
Ingestion
30%
Cell Function
23%
Glucagon
23%
Blood Plasma
23%
Glucose Level
23%
Insulin Release
15%
C-Peptide
15%
Secretion (Process)
15%
Glucose Test
7%
Glucagon Blood Level
7%
Glucose Tolerance Test
7%
Electrocardiogram
7%
QTc Interval
7%
Dofetilide
7%
QT Interval
7%
Small Interfering RNA
7%
Insulin Blood Level
7%
Glucose Blood Level
7%
Voltage-Gated Potassium Channel
7%
Glucagon Release
7%
Body Mass
7%
Blood Sampling
7%
Loss of Function Mutation
7%